Clinical trial · Observational
East-West Hepatocellular Carcinoma Study Group
EAST-WEST HEPATOCELLULAR CARCINOMA STUDY GROUP
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The current treatment guidelines of hepatocellular carcinoma (HCC) of the American and European Associations for the Study of Liver Disease are based on the Barcelona-Clinic-Liver-Cancer classification (BCLC), which does not recommend surgery in patients with large, multinodular and macrovascular invasive disease. The aim of this study was to investigate the role of hepatic resection in a large retrospective multicentric cohort of patients resected for HCC regardless of the BCLC indications.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Hepatocellular | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Overall survival of resected patients for HCC
- description
- The primary endpoint of the study was the overall survival of patients resected for HCC in any stage of the BCLC classification.
Secondary outcomes (1)
- measure
- Disease-free survival of resected patients for HCC
- description
- The secondary endpoint was the disease-free survival of patients resected for HCC among the BCLC stages.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * clinical diagnosis of hepatocellular carcinoma * candidate to liver resection as a curative treatment Exclusion Criteria: * uncertain diagnosis of hepatocellular carcinoma * uncertain follow-up data
References
Publications (0)
Data not yet available